Martoma was charged by the U.S. in November with the largest
insider trading case in history, accused of helping the hedge fund founded by
Steven A. Cohen make $276 million using illegal tips about a drug to treat
Alzheimer’s disease.
The U.S. Securities and Exchange Commission alleged that
Martoma’s source was Sid Gilman, a University
of Michigan neurologist
who was head of the safety monitoring committee for the drug trial. Gilman has
entered into a non-prosecution agreement and is cooperating with the
government.
No comments:
Post a Comment